RenovoRx (RNXT) Cash from Financing Activities (2024 - 2025)
RenovoRx's Cash from Financing Activities history spans 2 years, with the latest figure at $34000.0 for Q2 2025.
- For Q2 2025, Cash from Financing Activities fell 99.65% year-over-year to $34000.0; the TTM value through Sep 2025 reached $10.9 million, changed N/A, while the annual FY2024 figure was $15.1 million, 201.88% up from the prior year.
- Cash from Financing Activities for Q2 2025 was $34000.0 at RenovoRx, down from $10.8 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $10.8 million in Q1 2025 and bottomed at $15000.0 in Q3 2024.